Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: May 3, 2012
Reporting Period: Three months ended March 31, 2012
This filing serves as a notification that the Company issued a press release announcing financial results for the quarter ended March 31, 2012. The press release is included as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, no specific values for these metrics can be extracted from this document alone.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the issuance of a press release regarding Q1 2012 results but does not include the text of the commentary, guidance, or outlook.
Risks and Contingencies: No specific risks or contingencies are detailed in this cover document.
Unusual Items: None reported in this text.
Important Facts for Investor Verification
- Verify the specific revenue and net income figures in the attached press release (Exhibit 99.1), as they are not listed in the 8-K cover sheet.
- Confirm whether the results met or missed analyst expectations for the quarter ended March 31, 2012.
- Review the press release for any updated forward-looking guidance or changes in business strategy.
- Note that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act for liability purposes unless expressly incorporated by reference in other filings.